101
|
Piponniau L, Kittleson M, Patel J, Rafiei M, Osborne A, Dhiantravan V, Chang D, Czer L, Hage A, Hamilton M, Moriguchi J, Kobashigawa J. Mycophenolate Not Azathioprine Is Associated with Increased Risk for Skin Cancer after Heart Transplant. J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.490] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
102
|
Arulkumaran N, Corredor C, Hamilton M, Grounds M, Ball J, Rhodes A, Cecconi M. Treatment-related cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis. Crit Care 2013. [PMCID: PMC3642484 DOI: 10.1186/cc12133] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
103
|
Rahman I, Angelini G, Hamilton M, Bryan A. Pericardial Neo-Aorta to Bridge Long Segment Defects after Infected Aortic Reconstructions. J Card Surg 2013; 28:295-7. [DOI: 10.1111/jocs.12077] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
104
|
Aya HD, Cecconi M, Hamilton M, Rhodes A. Goal-directed therapy in cardiac surgery: a systematic review and meta-analysis. Br J Anaesth 2013; 110:510-7. [PMID: 23447502 DOI: 10.1093/bja/aet020] [Citation(s) in RCA: 166] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Perioperative mortality after cardiac surgery has decreased in recent years although postoperative morbidity is still significant. Although there is evidence that perioperative goal-directed haemodynamic therapy (GDT) may reduce surgical mortality and morbidity in non-cardiac surgical patients, the data are less clear after cardiac surgery. The objective of this review is to perform a meta-analysis on the effects of perioperative GDT on mortality, morbidity, and length of hospital stay in cardiac surgical patients. METHODS We conducted a systematic review using Medline, EMBASE, and the Cochrane Controlled Clinical Trials Register. Additional sources were sought from experts. The inclusion criteria were randomized controlled trials, mortality reported as an outcome, pre-emptive haemodynamic intervention, and cardiac surgical population. Included studies were examined in full and subjected to quantifiable analysis, subgroup analysis, and sensitivity analysis where possible. Data synthesis was obtained by using odds ratio (OR) and mean difference (MD) for continuous data with 95% confidence interval (CI) utilizing a random-effects model. RESULTS From 4986 potential studies, 5 met all the inclusion criteria (699 patients). The quantitative analysis showed that the use of GDT reduced the postoperative complication rate (OR 0.33, 95% CI 0.15-0.73; P=0,006) and hospital length of stay (MD -2.44, 95% CI -4.03 to -0.84; P=0,003). There was no significant reduction in mortality. CONCLUSION The use of pre-emptive GDT in cardiac surgery reduces morbidity and hospital length of stay.
Collapse
|
105
|
Greveson K, Capocci S, Murthy S, Smith C, Morris S, Murray C, Cropley I, Hamilton M, Lipman M. P57 Comparative Cost-Effectiveness of IGRA to Detect Latent TB Infection in UK Inflammatory Bowel Disease Patients Initiating Anti-TNFα Agents: Abstract P57 Table 1. Thorax 2012. [DOI: 10.1136/thoraxjnl-2012-202678.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
106
|
Cecconi M, Arulkumaran N, Suleman R, Shearn D, Geisen M, Mellinghoff J, Dawson D, Ball J, Hamilton M, Grounds M, Rhodes A. Oxygen delivery index during goal-directed therapy predicts complications and hospital length of stay in patients undergoing high-risk surgery. Crit Care 2012. [PMCID: PMC3363892 DOI: 10.1186/cc11081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
107
|
Rickman M, Young J, Bircher M, Pearce R, Hamilton M. The management of complex acetabular fractures in the elderly with fracture fixation and primary total hip replacement. Eur J Trauma Emerg Surg 2012; 38:511-6. [DOI: 10.1007/s00068-012-0231-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2012] [Accepted: 09/17/2012] [Indexed: 10/27/2022]
|
108
|
Jensen RL, Abraham S, Hu N, Jensen RL, Boulay JL, Leu S, Frank S, Vassella E, Vajtai I, von Felten S, Taylor E, Schulz M, Hutter G, Sailer M, Hench J, Mariani L, van Thuijl HF, Scheinin I, van Essen DF, Heimans JJ, Wesseling P, Ylstra B, Reijneveld JC, Borges AR, Larrubia PL, Marques JMB, Cerdan SG, Brastianos P, Horowitz P, Santagata S, Jones RT, McKenna A, Getz G, Ligon K, Palescandolo E, Van Hummelen P, Stemmer-Rachamimov A, Louis D, Hahn WC, Dunn I, Beroukhim R, Guan X, Vengoechea J, Zheng S, Sloan A, Chen Y, Brat D, O'Neill BP, Cohen M, Aldape K, Rosenfeld S, Noushmehr H, Verhaak RG, Barnholtz-Sloan J, Bahassi EM, Li YQ, Cross E, Li W, Vijg J, McPherson C, Warnick R, Stambrook P, Rixe O, Manterola L, Tejada-Solis S, Diez-Valle R, Gonzalez M, Jauregui P, Sampron N, Barrena C, Ruiz I, Gallego J, Delattre JY, de Munain AL, Mlonso MM, Saito K, Mukasa A, Nagae G, Aihara K, Takayanagi S, Aburatani H, Saito N, Kong XT, Fu BD, Du S, Hasso AN, Linskey ME, Bota D, Li C, Chen YS, Chen ZP, Kim CH, Cheong JH, Kim JM, Yelon NP, Jacoby E, Cohen ZR, Ishida J, Kurozumi K, Ichikawa T, Onishi M, Fujii K, Shimazu Y, Date I, Narayanan R, Ho QH, Levin BS, Maeder ML, Joung JK, Nutt CL, Louis DN, Thorsteinsdottir J, Fu P, Gehrmann M, Multhoff G, Tonn JC, Schichor C, Thirumoorthy K, Gordon N, Walston S, Patel D, Okamoto M, Chakravarti A, Palanichamy K, French P, Erdem L, Gravendeel L, de Rooi J, Eilers P, Idbaih A, Spliet W, den Dunnen W, Teepen J, Wesseling P, Smitt PS, Kros JM, Gorlia T, van den Bent M, McCarthy D, Cook RW, Oelschlager K, Maetzold D, Hanna M, Wick W, Meisner C, Hentschel B, Platten M, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, Schilling A, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M, Moren L, Johansson M, Bergenheim T, Antti H, Sulman EP, Goodman LD, Wani KM, DeMonte F, Aldape KD, Krischek B, Gugel I, Aref D, Marshall C, Croul S, Zadeh G, Nilsson CL, Sulman E, Liu H, Wild C, Lichti CF, Emmett MR, Lang FF, Conrad C, Alentorn A, Marie Y, Boisselier B, Carpetier C, Mokhtari K, Hoang-Xuan K, Capelle L, Delattre JY, Idbaih A, Lautenschlaeger T, Huebner A, McIntyre JB, Magliocco T, Chakravarti A, Hamilton M, Easaw J, Pollo B, Calatozzolo C, Vuono R, Guzzetti S, Eoli M, Silvani A, Di Meco F, Filippini G, Finocchiaro G, Joy A, Ramesh A, Smirnov I, Reiser M, Shapiro W, Mills G, Kim S, Feuerstein B, Gonda DD, Li J, McCabe N, Walker S, Goffard N, Wikstrom K, McLean E, Greenan C, Delaney T, McCarthy M, McDyer F, Keating KE, James IF, Harrison T, Mullan P, Harkin DP, Carter BS, Kennedy RD, Chen CC, Patel AS, Allen JE, Dicker DT, Rizzo K, Sheehan JM, Glantz MJ, El-Deiry WS, Salhia B, Ross JT, Kiefer J, Van Cott C, Metpally R, Baker A, Sibenaller Z, Nasser S, Ryken T, Ramanathan R, Berens ME, Carpten J, Tran NL, Bi Y, Pal S, Zhang Z, Gupta R, Macyszyn L, Fetting H, O'Rourke D, Davuluri RV, Ezrin AM, Moore K, Stummer W, Hadjipanayis CG, Cahill DP, Beiko J, Suki D, Prabhu S, Weinberg J, Lang F, Sawaya R, Rao G, McCutcheon I, Barker FG, Aldape KD, Trister AD, Bot B, Fontes K, Bridge C, Baldock AL, Rockhill JK, Mrugala MM, Rockne RR, Huang E, Swanson KR, Underhill HR, Zhang J, Shi M, Lin X, Mikheev A, Rostomily RC, Scheck AC, Stafford P, Hughes A, Cichacz Z, Coons SW, Johnston SA, Mainwaring L, Horowitz P, Craig J, Garcia D, Bergthold G, Burns M, Rich B, Ramkissoon S, Santagata S, Eberhart C, Ligon A, Goumnerova L, Stiles C, Kieran M, Hahn W, Beroukhim R, Ligon K, Ramkissoon S, Olausson KH, Correia J, Gafni E, Liu H, Theisen M, Craig J, Hayashi M, Haidar S, Maire C, Mainwaring LA, Burns M, Norden A, Wen P, Stiles C, Ligon A, Kung A, Alexander B, Tonellato P, Ligon KL. LAB-OMICS AND PROGNOSTIC MARKERS. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos231] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
109
|
Dickey T, Granata T, Marra J, Langdon C, Wiggert J, Chai-Jochner Z, Hamilton M, Vazquez J, Stramska M, Bidigare R, Siegel D. Seasonal variability of bio-optical and physical properties in the Sargasso Sea. ACTA ACUST UNITED AC 2012. [DOI: 10.1029/92jc01830] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
110
|
Khavandi A, Hamilton M, Martin R, Parry A, Brooks M, Baumbach A, Turner M. 044 Endovascular and transcatheter management of coarctation-related aneurysms in adults. BRITISH HEART JOURNAL 2012. [DOI: 10.1136/heartjnl-2012-301877b.44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
111
|
Curtis SL, Bradley M, Wilde P, Aw J, Chakrabarti S, Hamilton M, Martin R, Turner M, Stuart AG. Results of screening for intracranial aneurysms in patients with coarctation of the aorta. AJNR Am J Neuroradiol 2012; 33:1182-6. [PMID: 22322607 DOI: 10.3174/ajnr.a2915] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE IAs are found in 2.3% of adults; the mean age at detection is 52 years. Prevalence is <0.5% in young adults. Early studies suggest that 10%-50% of patients with aortic coarctation have IAs. Screening recommendations are variable. We sought to examine the prevalence of IAs through screening with MRA. MATERIALS AND METHODS Consecutive patients older than 16 years of age with coarctation undergoing brain MRA between May 1999 and October 2007 were included. MRA was performed by using a 1.5T scanner with a 3D time-of-flight protocol; simultaneous MR imaging was performed of the heart and aorta. Cerebral MRAs were double-reported by a neuroradiologist. Statistics are described as mean ± SD and median ± range. Continuous variables were compared by using Student t tests and Mann-Whitney U tests (categoric variables, by using the Fisher exact test). RESULTS One hundred seventeen MRAs were double-reported. The median age was 29 ± 11 years (range, 16-59 years). IAs were found in 12 patients (10.3%). The mean diameter of IAs was 3.9 mm (range, 2.0-8.0 mm). Patients with aneurysms were older (median, 37 years; range, 16-50 years) than those without (median, 23 years; range, 16-59 years; Z = -2.01, P = .04). Hypertension was more common in those with IAs (IA 83% versus no IA 43%, P = .01). There was no association between ascending aortopathy, bicuspid aortic valves, and IAs. CONCLUSIONS Patients with coarctation have a higher prevalence of IAs, occurring at an earlier age than in population studies. Whether routine screening is appropriate for this group of patients is unclear. Hypertension is likely to be an important pathophysiologic factor.
Collapse
|
112
|
Cecconi M, Caliandro F, Mellinghoff J, Dawson D, Ranjan S, Hamilton M, Grounds M, Rhodes A. Prediction of fluid responsiveness in intensive care (PREFERENCE study): fluid challenge versus passive leg raising in high-risk surgical patients. Crit Care 2012. [PMCID: PMC3363657 DOI: 10.1186/cc10846] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
113
|
Nyman Iliadou A, Ekberg S, Cnattingius S, Johansson ALV, Mutsaerts MAQ, Groen H, Buiter-Van der Meer A, Sijtsma A, Kuchenbecker WKH, Mol BW, Sauer PJJ, Land JA, Corpeleijn E, Hoek A, Bhattacharya S, Kurinczuk J, Lee A, Raja EA, Porter M, Hamilton M, Templeton A, Mollison J, Moore VM, Marino JL, Willson KJ, Davies MJ, Chambers GM, Zhu R, Hoang VP. REPRODUCTIVE EPIDEMIOLOGY AND HEALTH ECONOMY. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.89] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
114
|
Abstract
An earlier version of this paper was presented at the 2011 IEEE International Symposium on Technology and Society (ISTAS) at Saint Xavier University in Chicago, Illinois (and printed in the 2011 ISTAS proceedings).
This paper describes a proposed mobile platform,
Transafe
, that captures and analyses public perceptions of safety to deliver 'crowdsourced' collective intelligence about places in the City of Melbourne, Australia, and their affective states at various times of the day. Public perceptions of crime on public transport in Melbourne are often mismatched with actual crime statistics and such perceptions thus can act as social barriers to visitors and locals traversing within and through the city. Using interactive mobile applications and social media, the visualization of this crowdsourced safety perception information will increase the commuter's awareness of various situations in the City of Melbourne. In addition, through social behavioral analysis and ethnographic research, the collective public intelligence will also help inform the stakeholders of the city for future policy-making and policing strategies for safety perception management. At the centre of the proposed platform is the design and development of a mobile phone application that can contribute to people feeling safer by supporting users to report crimes and misdemeanors that they witness, and provide information about transportation and emergency services around where the users are located. The proposed application can also act as a crime deterrent with one feature that enables user tracking by up to three nominated friends if the user opts to activate tracking when feeling unsafe while roaming the city.
Collapse
|
115
|
Mita AC, Papadopoulos K, de Jonge MJA, Schwartz G, Verweij J, Mita MM, Ricart A, Chu QSC, Tolcher AW, Wood L, McCarthy S, Hamilton M, Iwata K, Wacker B, Witt K, Rowinsky EK. Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer. Br J Cancer 2011; 105:938-44. [PMID: 21878940 PMCID: PMC3185947 DOI: 10.1038/bjc.2011.332] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Revised: 07/22/2011] [Accepted: 08/01/2011] [Indexed: 11/08/2022] Open
Abstract
BACKGROUND To evaluate the anticancer activity of erlotinib in patients with previously treated, advanced non-small cell lung cancer (NSCLC) whose dose is increased to that associated with a maximal level of tolerable skin toxicity (i.e., target rash (TR)); to characterise the pharmacokinetics (PK) and pharmacodynamics (PD) of higher doses of erlotinib. METHODS Patients initially received erlotinib 150 mg per day. The dose was successively increased in each patient to that associated with a TR. Anticancer activity was evaluated. Plasma, skin, and hair were sampled for PK and PD studies. RESULTS Erlotinib dose escalation to 200-475 mg per day was feasible in 38 (90%) of 42 patients. Twenty-four (57%) patients developed a TR, but 19 (79%) did so at 150 mg per day. Five (12%) patients, all of whom developed a TR, had a partial response. Median progression-free survival (PFS) was 2.3 months (95% CI: 1.61, 4.14); median PFS was 3.5 months and 1.9 months, respectively, for patients who did and did not experience a TR (hazard ratio, 0.51; P=0.051). Neither rash severity nor response correlated with erlotinib exposure. CONCLUSION Intrapatient dose escalation of erlotinib does not appreciably increase the propensity to experience a maximal level of tolerable skin toxicity, or appear to increase the anticancer activity of erlotinib in NSCLC.
Collapse
|
116
|
Scotland GS, McLernon D, Kurinczuk JJ, McNamee P, Harrild K, Lyall H, Rajkhowa M, Hamilton M, Bhattacharya S. Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost-utility of elective single versus double embryo transfer over a 20-year time horizon. BJOG 2011; 118:1073-83. [DOI: 10.1111/j.1471-0528.2011.02966.x] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
117
|
Kittleson M, Patel J, Esmailian F, Trento A, Kass R, Kawano M, Goldstein Z, Rafiei M, Czer L, Hamilton M, Kobashigawa J. 578 Primary Graft Dysfunction: Autopsy Data Sheds Light on Pathogenesis. J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
118
|
Patel J, Moriguchi J, Stimpson E, Reinsmoen N, Reed E, Kawano M, Goldstein Z, Rafiei M, Hamilton M, Schwarz E, Kobashigawa J. 518 Success of Desensitization Protocol in Reducing Calculated Panel Reactive Antibodies in a Large Cohort of Sensitized Heart Transplant Candidates. J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
119
|
Patel J, Kittleson M, Kawano M, Goldstein Z, Rafiei M, Barry O, Hamilton M, Schwarz E, Esmailian F, Kobashigawa J. 528 Does Gender Mismatch Increase the Risk of Antibody-Mediated Rejection (AMR) after Heart Transplantation? J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
120
|
Patel J, Kittleson M, Kawano M, Goldstein Z, Stimpson E, Rush J, Rafiei M, Reinsmoen N, Reed E, Hamilton M, Trento A, Kobashigawa J. 41 The Effects of Moderate Strength Pre-Transplant Circulating Antibodies on Outcome after Heart Transplantation. J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
121
|
Kenny DP, Hamilton M, Martin R. CT or MRI for post-procedural aortic stenting? BRITISH HEART JOURNAL 2011; 97:164; author reply 165. [DOI: 10.1136/hrt.2010.209684] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
122
|
Hamilton M. INVITED SESSION, SESSION 23: DEBATE - THIS HOUSE BELIEVES THAT OBESE WOMEN SHOULD NOT RECEIVE TREATMENT UNTIL THEY HAVE LOST WEIGHT, Monday 4 July 2011 17:00 - 18:00. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.23] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
123
|
Krauze A, Patel S, Ghosh S, Roa W, Abdulkarim B, Murtha A, Hamilton M. Prognostic Factors for Survival and Recurrence in Adult Medulloblastoma. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
124
|
Hamilton M, Bernardino A, Liu Y, Provoncha K, Paul D, Rotshteyn Y, Han A, Qian D. 65 Targeting Ras-mutated tumors with novel multiplex PI3K inhibitors through inhibition of eIF-4E-mediated protein translation. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)71770-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
125
|
Ilhan A, Wagner L, Maj M, Woehrer A, Czech T, Heinzl H, Marosi C, Base W, Preusser M, Jeuken JW, Navis AC, Sijben A, Boots-Sprenger SH, Bleeker FE, Gijtenbeek JM, Wesseling P, Seyed Sadr E, Tessier A, Seyed Sadr M, Alshami J, Anan M, Sabau C, Del Maestro R, Agnihotri S, Gajadhar A, Wolf A, Mischel PM, Hawkins C, Guha A, Guan X, Chance MR, Barnholtz-Sloan JS, Larson JD, Rodriguez FJ, Demer AM, Sarver AL, Dubac A, Jenkins RB, Dupuy AJ, Copeland NG, Jenkins NA, Taylor MD, Largaespada DA, Lusis EA, Stuart JE, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH, Barnholtz-Sloan JS, Adams MD, Cohen M, Devine K, Wolinsky Y, Bambakidis N, Selman W, Miller R, Sloan AE, Suchorska B, Mehrkens JH, Eigenbrod S, Eroes CA, Tonn JC, Kretzschmar HA, Kreth FW, Buczkowicz P, Bartels U, Morrison A, Zarghooni M, Bouffet E, Hawkins C, Kollmeyer TM, Wrensch M, Decker PA, Xiao Y, Rynearson AL, Fink S, Kosel ML, Johnson DR, Lachance DH, Yang P, Fridley BL, Wiemels J, Wiencke J, Jenkins RB, Zhou YH, Hess KR, Yu L, Raj VR, Liu L, Alfred Yung WK, Hutchins LF, Linskey ME, Roldan G, Kachra R, McIntyre JB, Magliocco A, Easaw J, Hamilton M, Northcott PA, Van Meter T, Eberhart C, Weiss W, Rutka JT, Gupta N, Korshunov A, French P, Kros J, Michiels E, Kloosterhof N, Hauser P, Montange MF, Jouvet A, Bouffet E, Jung S, Kim SK, Wang KC, Cho BK, Di Rocco C, Massimi L, Leonard J, Scheurlen W, Pfister S, Robinson S, Yang SH, Yoo JY, Cho DG, Kim HK, Kim SW, Lee SW, Fink S, Kollmeyer T, Rynearson A, Decker P, Sicotte H, Yang P, Jenkins R, Lai A, Kharbanda S, Tran A, Pope W, Solis O, Peale F, Forrest W, Purjara K, Carrillo J, Pandita A, Ellingson B, Bowers C, Soriano R, Mohan S, Yong W, Aldape K, Mischel P, Liau L, Nghiemphu P, James CD, Prados M, Westphal M, Lamszus K, Cloughesy T, Phillips H, Thon N, Kreth S, Eigenbrod S, Lutz J, Ledderose C, Tonn JC, Kretzschmar H, Kreth FW, Mokhtari K, Ducray F, Kros JM, Gorlia T, Idbaih A, Marie Y, Taphoorn M, Wesseling P, Brandes AA, Hoang-Xuan K, Delattre JY, Van den Bent M, Sanson M, Lavon I, Shahar T, Granit A, Smith Y, Nossek E, Siegal T, Ram Z, Marko NF, Quackenbush J, Weil RJ, Ducray F, Criniere E, Idbaih A, Paris S, Marie Y, Carpentier C, Houillier C, Dieme M, Adam C, Hoang-Xuan K, Delattre JY, Duyckaerts C, Sanson M, Mokhtari K, Zinn PO, Kozono D, Kasper EM, Warnke PC, Chin L, Chen CC, Saito K, Mukasa A, Saito N, Stieber D, Lenkiewicz E, Evers L, Vallar L, Bjerkvig R, Barrett M, Niclou SP, Gorlia T, Brandes A, Stupp R, Rampling R, Fumoleau P, Dittrich C, Campone M, Twelves C, Raymond E, Lacombe D, van den Bent MJ, Potter N, Ashmore S, Karakoula K, Ward S, Suarez-Merino B, Luxsuwong M, Thomas DG, Darling J, Warr T, Gutman DA, Cooper L, Kong J, Chisolm C, Van Meir EG, Saltz JH, Moreno CS, Brat DJ, Brennan CW, Brat DJ, Aldape KD, Cohen M, Lehman NL, McLendon RE, Miller R, Schniederjan M, Vandenberg SR, Weaver K, Phillips S, Pierce L, Christensen B, Smith A, Zheng S, Koestler D, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, Kelsey KT, Wiencke JK, Al-Nedawi K, Meehan B, Micallef J, Guha A, Rak J. -Omics and Prognostic Markers. Neuro Oncol 2010. [DOI: 10.1093/neuonc/noq116.s8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|